We are live on ! Find out more
ERNA icon

Eterna Therapeutics
ERNA

5 hedge funds and large institutions have $5.46M invested in Eterna Therapeutics in 2013 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

196% more capital invested

Capital invested by funds: $1.84M → $5.46M (+$3.61M)

67% more funds holding

Funds holding: 3 → 5 (+2)

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MHP
Manatuck Hill Partners
Connecticut
+$1.75M
2
EAM
Eagle Asset Management
Florida
+$437K

Top Sellers

Rank Fund Capital Flow
1
SKK
Shepherd Kaplan Krochuk
Massachusetts
-$35K
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
1
Eagle Asset Management
Florida
$2.17M +$437K +1 +25%
MHP
2
Manatuck Hill Partners
Connecticut
$1.18M +$1.75M +4 New
GPCM
3
Granite Point Capital Management
Massachusetts
$630K +$874K +2 New
Renaissance Technologies
4
Renaissance Technologies
New York
$451K – – –
SONJCPFA
5
State of New Jersey Common Pension Fund A
New Jersey
$315K – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$223K – – –
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$150K – – –
Bank of America
8
Bank of America
North Carolina
$111K – – –
BIT
9
BlackRock Institutional Trust
California
$79K – – –
OC
10
Oppenheimer & Co
New York
$63K – – –
Geode Capital Management
11
Geode Capital Management
Massachusetts
$31K – – –
Northern Trust
12
Northern Trust
Illinois
$21K – – –
U
13
UBS
Switzerland
$19K – – –
Goldman Sachs
14
Goldman Sachs
New York
$7K – – –
Bessemer Group
15
Bessemer Group
New Jersey
$1K – – –
Morgan Stanley
16
Morgan Stanley
New York
$1K – – –
Manulife (Manufacturers Life Insurance)
17
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4 – – –
SKK
18
Shepherd Kaplan Krochuk
Massachusetts
– -$35K – –

ERNA Hedge Fund Activity: Q4 2013 in Review

5 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q4 2013, worth a combined $5.46M — up 196% from $1.84M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ERNA positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Manatuck Hill Partners, opening a new position worth an estimated $1.75M. The largest seller was Shepherd Kaplan Krochuk, cutting an estimated $35K.

  • 5 institutional investors held Eterna Therapeutics (ERNA) as of Q4 2013, up from 3 in Q3 2013.
  • Funds reported $5.46M of Eterna Therapeutics stock for Q4 2013, up 196% quarter-over-quarter.
  • 2 funds opened new Eterna Therapeutics positions in Q4 2013 and 0 closed out, a net change of +2 holders.
  • The largest Eterna Therapeutics buyer in Q4 2013 was Manatuck Hill Partners, an estimated $1.75M added.
  • The largest Eterna Therapeutics seller in Q4 2013 was Shepherd Kaplan Krochuk, an estimated $35K sold.

Based on aggregated 13F filings for Q4 2013.